Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Manage your formulary budget
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Method for treating borderline personality disorder with serotonin re-uptake blockers|
|Abstract:||There is disclosed a method for treating borderline personality disorder in a patient by administering a nontoxic dose of a serotonin re-uptake blocker. Preferably, the serotonin re-uptake blocker is fluoxetine or norfluoxetine.|
|Inventor(s):||Norden; Michael J. (Seattle, WA)|
|Filing Date:||Jan 25, 1994|
|Claims:||1. A method for treating borderline personality disorder in a patient in need thereof comprising administering to said patient a nontoxic dose of a serotonin re-uptake blocker. |
2. The method of claim 1 wherein the serotonin re-uptake blocker is selected from the group consisting of fluoxetine, zimelidine, fluvoxamine, seataline, indalpine, citalopram, femoxetine, paroxetine, alaproclate and derivatives thereof and pharmaceutically acceptable salts thereof.
3. The method of claim 2 wherein the serotonin re-uptake blocker is fluoxetine or norfluoxetine.
4. The method of claim 3 wherein the dose of fluoxetine or norfluoxetine is from about 2 mg to about 80 mg daily.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.